Krystal Biotech Ownership | Who Owns Krystal Biotech?


OverviewForecastRevenueFinancialsChartTranscripts

Krystal Biotech Ownership Summary


Krystal Biotech is owned by 104.18% institutional investors, 10.93% insiders. Fmr is the largest institutional shareholder, holding 15.09% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.11% of its assets in Krystal Biotech shares.

KRYS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKrystal Biotech104.18%10.93%-15.10%
SectorHealthcare Stocks 50.51%12.37%37.12%
IndustryBiotech Stocks 48.95%12.07%38.98%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr4.42M15.09%$1.64B
Blackrock funding, inc. /de4.18M14.28%$1.55B
Blackrock3.95M13.95%$724.98M
Avoro capital advisors2.89M9.86%$1.07B
Vanguard group2.78M9.60%$685.10M
State street1.35M4.61%$502.20M
Vanguard capital management1.24M4.24%$461.08M
Soleus capital management939.25K3.21%$349.09M
Capital world investors777.84K2.66%$289.10M
Vestor capital700.91K2.39%$78.19M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group632.00K15.77%$234.90M
Soleus capital management939.25K12.03%$349.09M
Act capital management45.00K10.93%$16.73M
Avoro capital advisors2.89M9.64%$1.07B
S squared77.55K8.94%$28.82M
Evolutionary tree capital management8.30K5.82%$3.09M
Palisades investment partners47.80K5.05%$17.77M
Vestor capital700.91K4.91%$78.19M
Frazier life sciences management481.31K3.90%$178.89M
Biondo investment advisors70.94K3.23%$26.37M

Top Buyers

HolderShares% AssetsChange
Blackrock3.95M0.02%2.14M
Vestor capital700.91K4.91%700.71K
Norges bank259.03K0.01%259.03K
Sixth street partners management company254.83K0.01%254.83K
Blackrock funding, inc. /de4.18M0.02%240.98K

Top Sellers

HolderShares% AssetsChange
Bellevue group77.53K0.61%-404.25K
Soleus capital management939.25K12.03%-213.83K
T. rowe price investment management---185.55K
Baker bros. advisors lp---169.93K
Lord, abbett---151.22K

New Positions

HolderShares% AssetsChangeValue
Norges bank259.03K0.01%259.03K$96.27M
Sixth street partners management company254.83K0.01%254.83K$94.71M
Westfield capital management co lp98.71K0.12%98.71K$36.69M
Eagle asset management76.26K0.07%76.26K$13.90M
Congress asset management co /ma40.13K0.09%40.13K$14.92M

Sold Out

HolderChange
Tfc financial management-1.00
Tortoise investment management-1.00
Ameritas advisory services-1.00
Tradewinds capital management-1.00
Kilter group-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202643514.47%30,510,9297.56%1041.08%26824.65%1104.76%
Mar 31, 2026234-31.78%12,018,941-57.72%410.43%135-30.77%60-43.40%
Dec 31, 2025232-22.15%16,100,358-42.52%550.59%128-16.88%74-12.94%
Sep 30, 20252894.33%27,787,3363.78%961.12%1497.19%83-10.75%
Jun 30, 2025280-10.26%27,626,5581.12%951.06%140-8.50%94-16.07%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Select Biotechnology1.80M6.11%-
iShares Core S&P Small-Cap ETF1.58M5.36%222.00
Fidelity Growth Compy Commingled Pl S1.07M3.62%20.90K
Fidelity Growth Compy Commingled Pl O915.43K3.19%-
iShares Core S&P Mid-Cap ETF901.22K3.04%28.00
Vanguard Total Stock Mkt Idx Inv889.73K3.02%51.28K
Vanguard Morn Total Stk Mkt Idx Investor889.73K3.02%51.28K
Vanguard MStar Total Stk Mkt Idx Invest892.45K3.02%2.72K
Vanguard US Total Market Shares ETF824.72K2.86%704.00
Fidelity Growth Company Fund805.13K2.72%16.61K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 14, 2026ROSSI DINO A-Sell$554.21K
Aug 14, 2026ROSSI DINO A-Sell$1.71M
Aug 14, 2026ROSSI DINO A-Sell$746.94K
Aug 14, 2026ROSSI DINO A-Sell$111.03K
Aug 14, 2026ROSSI DINO A-Sell$2.45M

Insider Transactions Trends


DateBuySell
2026 Q3-8
2026 Q2-24
2026 Q1-52
2025 Q4-32
2025 Q3-30

KRYS Ownership FAQ


Who Owns Krystal Biotech?

Krystal Biotech shareholders are primarily institutional investors at 104.18%, followed by 10.93% insiders and -15.11% retail investors. The average institutional ownership in Krystal Biotech's industry, Biotech Stocks , is 48.95%, which Krystal Biotech exceeds.

Who owns the most shares of Krystal Biotech?

Krystal Biotech’s largest shareholders are Fmr (4.42M shares, 15.09%), Blackrock funding, inc. /de (4.18M shares, 14.28%), and Blackrock (3.95M shares, 13.95%). Together, they hold 43.31% of Krystal Biotech’s total shares outstanding.

Does Blackrock own Krystal Biotech?

Yes, BlackRock owns 13.95% of Krystal Biotech, totaling 3.95M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 724.98M$. In the last quarter, BlackRock increased its holdings by 2.14M shares, a 118.67% change.

Who is Krystal Biotech’s biggest shareholder by percentage of total assets invested?

Redmile group is Krystal Biotech’s biggest shareholder by percentage of total assets invested, with 15.77% of its assets in 632K Krystal Biotech shares, valued at 234.9M$.

Who is the top mutual fund holder of Krystal Biotech shares?

Fidelity Select Biotechnology is the top mutual fund holder of Krystal Biotech shares, with 6.11% of its total shares outstanding invested in 1.8M Krystal Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools